Impact Factor
2.93
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.85
303 total citations
h5-index
28
h5 depth signal
Cited share
48.0%
82 of 171
Total citations
303
Citation footprint
Metric signal
2.11
External metric anchor
Self-citation
1.3%
4 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
146
United States
126
India
66
United Kingdom
35
Brazil
19
Citing Fields of Research
Mass Spectrometry
181
Genetics & Genomics
107
Noncoding RNA
46
Oncology
36
Cell Biology
36
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
679
Articles tracked across the journal lifetime
Indexed publication set
171
82 cited publications
Last 12 months
44
4.4 publications/month
Open access share
50.0%
22 OA publications in the last year
Leading citing country
China
146 citing publications
Leading citing field
Mass Spectrometry
181 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v14n1, 2018-
v14n1, 2018-
Research Focus & Classification
Indexed Subjects
Mass Spectrometry
Genetics & Genomics
Lipids
Cancer, Autophagy & Apoptosis
Kidney Diseases
Oncology
Issuing & Sponsoring Bodies
issuing body
Royal Society of Chemistry (Great Britain)
Broad Categories
Biochemistry
Molecular Biology
Mass Spectrometry
Noncoding RNA
Genetics & Genomics
Fungal Pathogenesis
Inflammatory Bowel Diseases & Infections
Musculoskeletal Disorders
MeSH Descriptors
Computational Biology
Molecular Biology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1093/molecular-omics/aaiag024
Open DOI
Identification of Novel Salivary Metabolite Biomarkers for Oral Squamous Cell Carcinoma Using Untargeted UHPLC-MS/MS Metabolomic Profiling
This study aimed to identify candidate salivary metabolites for differentiating oral squamous cell carcinoma (OSCC) patients from healthy controls. Untargeted metabolomics was performed using an Orbitrap UHPLC-MS/MS system on saliva samp...
02
DOI 10.1093/molecular-omics/aaiag023
Open DOI
Reference-based cell type deconvolution using self-supervised contrastive learning in spatial transcriptomics with ctdecon
It is important to analyse the cell types in the spatial domain at the single-cell resolution, especially in spatial transcriptomics (ST). It is also key to present the cell types distributed in the spatial domain. Here, we introduce ctd...
03
DOI 10.1093/molecular-omics/aaiag022
Open DOI
Baseline cellular state shapes the molecular impact of mutant Kirsten rat sarcoma viral oncogene homologue ( KRAS ) alleles in reconstituted pancreatic cancer cells
Kirsten rat sarcoma viral oncogene homologue (KRAS) is mutated in over 90% of pancreatic ductal adenocarcinomas (PDAC), where hotspot alterations in codons 12, 13, and 61 drive tumour initiation and progression. Although distinct biochem...
04
DOI 10.1093/molecular-omics/aaiag021
Open DOI
Proteomic analysis reveals a metabolic switch and cellular remodelling in pancreatic-like cell spheroids cocultured with hepatocyte-like cells using an interconnected liver-pancreas-on-chip system
Systemic interactions between the liver and pancreas are critical for regulating lipid and carbohydrate homeostasis. These organs are also deeply interdependent in pathological conditions such as insulin resistance, where the liver fails...
05
DOI 10.1093/molecular-omics/aaiag020
Open DOI
Rapid serum proteome profiling of glycation and N-glycosylation in women with a history of gestational diabetes
Here, we developed and validated a high throughput proteomics workflow that enables combined profiling of global proteomes and post-translational modifications (PTMs) without conventional enrichment or fractionation. Using mass spectrome...
06
DOI 10.1093/molecular-omics/aaiag019
Open DOI
Elevated urea levels in human frontotemporal dementia and amyotrophic lateral sclerosis post-mortem brain tissue: Evidence of a multi-dementia pathogenic mechanism
Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) represent two neurodegenerative diseases on opposite sides of a movement disorder continuum. However, like many other neurodegenerative diseases, the molecular pathoge...
07
DOI 10.1093/molecular-omics/aaiag018
Open DOI
Metabolite-centric identification of antimetabolite drug targets across cancer and neurodegenerative diseases
Antimetabolites, primarily studied in cancer, are novel drugs targeting metabolic networks by mimicking and inhibiting disease-causing metabolites, enabling poly-pharmacologic effects essential for complex diseases. Moreover, predicting ...
08
DOI 10.1093/molecular-omics/aaiag017
Open DOI
Platelet proteomics on less than a drop of previously frozen, non-citrate plasma
Platelets are blood components not regularly analysed with proteomics due to the conventional wisdom that plasma for platelet research must be citrate-treated and freshly sampled to minimize artifactual changes. Information from platelet...
09
DOI 10.1093/molecular-omics/aaiag016
Open DOI
Decoding the diabetic transition: a lipidomic approach for biomarker discovery in an Indian cohort
Type 2 diabetes mellitus (T2DM) is a significant public health burden in India, where the disease presents with unique clinical characteristics, yet data from this high-risk population remain scarce. This study aimed to conduct a lipidom...
10
DOI 10.1093/molecular-omics/aaiag015
Open DOI
Placental metabolomics for assessment of pregnancy complications: a systematic review
Metabolomics is a powerful tool for understanding biological function at the cellular level. While this omics technology has found application in areas ranging from toxicology to cancer, its potential for the study of human pregnancy com...